As of 2026-10-17, the EV/EBITDA ratio of Biodesix, Inc. (BDSX) is -18.49. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Biodesix,'s latest enterprise value is 261.94 mil USD. Biodesix,'s TTM EBITDA according to its financial statements is -14.17 mil USD. Dividing these 2 quantities gives us the above Biodesix, EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 7.7x - 8.7x | 8.0x |
| Forward P/E multiples | 8.4x - 9.4x | 8.9x |
| Fair Price | (13.06) - (13.55) | (13.21) |
| Upside | -155.2% - -157.3% | -155.8% |
| Date | EV/EBITDA |
| 2026-10-16 | -18.49 |
| 2026-10-15 | -19.26 |
| 2026-10-14 | -18.73 |
| 2026-10-13 | -19.47 |
| 2026-10-12 | -19.98 |
| 2026-10-09 | -20.21 |
| 2026-10-08 | -19.93 |
| 2026-10-07 | -20.51 |
| 2026-10-06 | -21.63 |
| 2026-10-05 | -22.44 |
| 2026-10-02 | -21.46 |
| 2026-10-01 | -21.17 |
| 2026-09-30 | -23.00 |
| 2026-09-29 | -22.50 |
| 2026-09-28 | -23.43 |
| 2026-09-25 | -22.47 |
| 2026-09-24 | -22.69 |
| 2026-09-23 | -22.60 |
| 2026-09-22 | -21.77 |
| 2026-09-21 | -21.98 |
| 2026-09-18 | -22.54 |
| 2026-09-17 | -22.25 |
| 2026-09-16 | -22.07 |
| 2026-09-15 | -21.44 |
| 2026-09-14 | -21.22 |
| 2026-09-11 | -20.90 |
| 2026-09-10 | -20.23 |
| 2026-09-09 | -20.99 |
| 2026-09-08 | -20.66 |
| 2026-09-04 | -20.33 |
| 2026-09-03 | -20.55 |
| 2026-09-02 | -21.05 |
| 2026-09-01 | -19.52 |
| 2026-08-31 | -20.45 |
| 2026-08-28 | -20.81 |
| 2026-08-27 | -22.01 |
| 2026-08-26 | -23.56 |
| 2026-08-25 | -21.72 |
| 2026-08-24 | -19.75 |
| 2026-08-21 | -20.66 |
| 2026-08-20 | -18.76 |
| 2026-08-19 | -19.86 |
| 2026-08-18 | -17.52 |
| 2026-08-17 | -18.19 |
| 2026-08-14 | -18.74 |
| 2026-08-13 | -18.58 |
| 2026-08-12 | -18.90 |
| 2026-08-11 | -18.96 |
| 2026-08-10 | -19.37 |
| 2026-08-07 | -18.37 |